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Summary 
Signal transduction molecules within the two-compo- 
nent family represent a conserved adaptation for the 
control of genes involved in pathogenesis. The Borde- 
tella virulence control locus, bvgAS, activates and re- 
presses gene expression in response to environmental 
signals. While infection requires virulence gene acti- 
vation, the role of gene repression during infection 
is not understood. By altering regulatory genes and 
reversing regulatory connections, we found evidence 
that the BvgAS-repressed genes responsible for motil- 
ity are neither required nor expressed during coloniza- 
tion of the host. Expression of this Bvg- phase-spe- 
cific phenotype in the Bvg ÷ growth phase resulted in 
a defect in tracheal colonization. Therefore, BvgAS 
promotes virulence both by activating genes required 
for colonization and by repressing genes that inhibit 
the development of infection. 
Introduction 
Host-microbe interactions exert selection for organisms 
that can acquire information and ~se it to influence the 
outcome of infection. Two-component signal transduction 
systems are thought to represent a primary mechanism 
supplying bacterial pathogens with information about the 
host environment (reviewed by Miller et al., 1989; Parkin- 
son, 1993). A sensor component, typically found in the 
plasma membrane, transfers a phosphoryl group to a regu- 
lator component hat effects a change in bacterial behavior 
or gene expression (reviewed by Stock et al., 1989; Parkin- 
son and Kofoid, 1992). Although a number of such systems 
have been implicated in bacterial virulence, their roles in 
facilitating interactions with the host are not well under- 
stood. The bacterial genus Bordetella provides a paradigm 
for the mechanisms used by microbial pathogens to inter- 
act with and respond to the host environment. Bordetella 
are gram-negative bacteria that infect the respiratory 
tracts of a variety of animals, producing a spectrum of 
manifestations. Bordetella pertussis causes paroxysmal 
coughing in humans, Bordetella avium causes coryza in 
turkeys, and Bordetella bronchiseptica induces atrophic 
rhinitis in pigs and persistent, asymptomatic infections in 
rabbits. Studies of Bordetella pathogenesis implicate sig- 
nal transduction by the prokaryotic ell in the production 
and maintenance of infection. All of the currently known 
genes associated with Bordetella pathogenesis are coor- 
dinately regulated by a single locus, bvgAS, also desig- 
nated vir (Stibitz et al., 1989), whose biochemical proper- 
ties and predicted amino acid sequence place it within 
the two-component family of signal-transducing proteins 
(Arico et al., 1989; Uhl and Miller, 1994). 
Consistent with the two-component paradigm, the 
bvgAS locus encodes proteins that transmit extracellular 
signals to the cellular transcription machinery, causing 
changes in gene expression (Miller et al., 1992). This sig- 
nal transduction event can be induced in the laboratory 
by altered growth conditions, resulting in a morphogenic 
transition between two distinct phenotypic phases (Figure 
1A). One phase (Bvg ÷) requires BvgAS and is character- 
ized by the induction of vir-activated genes (vags), a class 
of loci including genes encoding the adhesins and toxins 
that comprise most of the known virulence factors (Weiss 
et al., 1983). The other phase (Bvg-) is defined by the 
absence of vag-encoded factors and the expression of a 
class of genes called vir-repressed genes (vrgs). The vrgs 
include genes required for motility in B. bronchiseptica 
(Akerley and Miller, 1993) and genes required for the pro- 
duction of a number of outer membrane proteins in B. 
pertussis (Beattie et al., 1990). The Bvg- phase occurs 
when bvg is deleted or when BvgAS activity is suppressed 
by specific yet diverse experimental conditions, including 
the presence of sulfate anion, nicotinic acid, or reduced 
temperature (25°C versus 37°C). The signals that modu- 
late BvgAS activity in nature have not been identified, and 
the role of the BvgAS-mediated response to signals is not 
known. It is tempting to speculate that BvgAS controls 
gene expression patterns in response to signals present 
in the host to optimize the development of a successful 
infection. 
Comparison of the bvgAS genes of B. pertussis and 
B. bronchiseptica reveals 96% identity in their predicted 
amino acid sequences (Arico et al., 1991). B. bronchisep- 
tica expresses vags similar to each of the known virulence 
genes of B. pertussis, with the exception of the pertussis 
toxin gene, ptx. These species are highly related at the 
DNA level and have been classified as subspecies on the 
basis of 23S ribosomal RNA gene sequences (M~ller and 
Hildebrandt, 1993). Despite these similarities, the two spe- 
cies infect different hosts, potentially as a result of differ- 
ences in their respective BvgAS regulons. The difference 
in host tropism can be exploited experimentally, since B. 
bronchiseptica infects a variety of laboratory animals, per- 
mitting studies of the natural infection process. This level 
of resolution is not available in studies of B. pertussis, for 
which humans represent the only natural host. Under- 
standing the complete set of traits that allow a pathogen 
to thrive requires an experimental system in which all of 
these features are effective. 
While pathogenesis clearly requires vags, the impor- 
tance of vrg expression remains enigmatic. The produc- 
tion of flagella comprises a distinctive phenotype indica- 
tive of Bvg- phase gene expression. The link between the 
regulation of motility and virulence factors in B. bronchi- 
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Figure 1. The BvgAS-Mediated Phase Transition and the Flagellar 
Regulon 
(A) Active BvgS autophosphorylates on a conserved histidine residue 
in the transmitter domain (hatched box) and, by a mechanism involving 
the BvgS receiver domain (solid box), transfers a phosphoryl group 
to the receiver domain of BvgA (Uhl and Miller, 1994). Phosphorylated 
BvgA controls transcription via a regulator domain with DNA-binding 
activity (oval) (Boucher et al., 1994). BvgAS induces expression of 
factors implicated inadherence (spikes) such as FHA, pill, and pertac- 
tin and toxins such as pertussis toxin, adenylate cyclase toxin, and 
dermonecrotic oxin (dots). These factors, with the exception of pertus- 
sis toxin, are expressed in both B. pertussis and B. bronchiseptica. 
Inactivation ofBvgA$ in response to signals (termed phenotypic modu- 
lation) results in the Bvg growth phase. Bvg- phase B. bronchiseptica 
produce peritrichous flagella, while B. pertussis produces vrg-6 and 
several outer membrane proteins. 
(B) Motility in B. bronchiseptica is compared with that of the E. coil 
flagellar egulon (described in the text). BvgAS negatively controls 
motility and the transcription of two operons required for flagellum 
production, frlAB and flaA. flaA encodes flagellin, while frlAB encodes 
an activator of flagellar genes that efficiently complements mutations 
in the flhDC locus of E. coll. The transcriptional start site of flaA in B. 
bronchiseptica maps near a consensus recognition sequence found 
in aF-dependent promoters (matches to consensus are in bold type), 
and expression of a flaA-lacZfusion introduced into the E. coil chromo- 
some requires GF, suggesting the presence of a iliA analog (circled) 
in Bordetella. The DNA region 5' of the flhD protein-coding region 
contains a possible CRP-cAMP-binding site (hatched box). This con- 
sensus is not found near the transcriptional start site of frl. A DNA 
sequence (TAGAAA-nl 6-TAAA'I-[') that resembles the consensus rec- 
ognition site forthe E. coli major sigma factor a TM is found 5 bp upstream 
of the transcriptional start site of frl. It is not known whether these 
flagellar control factors regulate genes other than those involved in 
the production of motility. 
septica suggests that motility control plays a role in paths- 
genesis. To address the functional significance of vrg ex- 
pression and negative control by BvgAS, we investigated 
flagellar egulation. Comparisons with the flagellar hierar- 
chy of Escherichia coil proved useful in analyzing the fla- 
gellar regulon of B. bronchiseptica. FlageUar synthesis 
proceeds as a cascade of transcriptional control events 
leading to the ordered expression and assembly of struc- 
tural proteins that comprise the flagellar organelle (re- 
viewed by Macnab, 1992). In E. coil, glucose starvation 
leads to increased production of cAMP, which functions 
as a coactivator with catabolite repression protein (CRP) 
to promote expression of the f lhDC locus (Silverman and 
Simon, 1977). f lhD and f lhC are early genes of the flagellar 
hierarchy that encode products required for transcription 
of middle and late genes (Komeda, 1982). A B. bronchisep- 
tica locus, frl (for flagellar-regulatory locus), complements 
f lhDC mutations in E. coil (Akerley and Miller, 1993). Mid- 
dle genes include i l iA, which encodes an alternative sigma 
factor, c F, required for transcription of late gene promot- 
ers, including the promoter for f//C encoding flagellin. The 
Bordetella flaA gene encodes a flagellin protein with 61% 
amino acid identity to that of E. coil and contains the E. coil 
~F consensus near its transcriptional start site. In addition, 
f laA requires i l iA for heterologous expression in E. coil 
(Akerley and Miller, 1993). These findings suggested a 
model for a BvgAS-regulated transcriptional cascade con- 
trolling the motility phenotype in B. bronchiseptica (Fig- 
ure 1 B). 
This report describes an analysis of BvgAS-mediated 
regulation of motility and the modification of this genetic 
circuitry to test the role of negative control by BvgAS in 
the context of the natural environment of Bordetella within 
a host. The results indicate that BvgAS negatively controls 
a regulatory locus, frlAB, that is required for the production 
of flagellar organelles. We reversed the expression pattern 
of frl by fusing the operon to a BvgAS-activated promoter. 
This genetic alteration induced motility in the Bvg ÷ growth 
phase, in which motility is not normally produced. Ectopic 
expression of frl during the development of a natural respi- 
ratory infection reduced colonization by B. bronchiseptica, 
demonstrating a requirement for both positive and nega- 
tive regulation by BvgAS during colonization. We propose 
that one function of signal transduction by virulence con- 
trol systems consists of preventing the expression of bac- 
terial phenotypes that would otherwise attenuate the viru- 
lence of the infecting organism. 
Results 
The Link between Motility and the Virulence 
Control System 
Initial comparisons between the flagellar genes of B. bron- 
chiseptica and E. coil indicated that the frl  locus may en- 
code a f lhDC analog. Transcription of all flagellar genes 
in E. coil that have been tested requires f lhDC. Therefore, it 
seemed likely that BvgAS could control motility by exerting 
negative control at the frl promoter. This hypothesis was 
investigated by primer extension analysis of B. bronchi- 
septica RNA (Figure 2). Transcription from the frl promoter 
was compared with that of the autoregulated bvg promot- 
ers (Pl~vg and P2bvg). Expression of Plbv.q requires active 
BvgAS, while P2~vg is expressed only when BvgAS is inac- 
tive (Roy et al., 1990; Scarlato et al., 1990). RNA samples 
in which the state of BvgAS activation had been defined 
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Figure 2. Transcriptional Control of frl by 13vgAS 
Primer extension analysis of total cellular ~NA with primers pecific 
to bvgA (bvg) or frlA (frO. The genotypes of strains examined are listed 
above each lane. Strain designations are as follows: wt, GP1SN; 
dbvgAS, DM107; and bvgS-C3, DM106. The .4bvgAS strain serves 
as a negative control for bvg primer specificity, since the primer- 
binding site is deleted in this strain. Use of an additional primer specific 
to frlA yielded the same result (data not shown). The product detected 
corresponds to a position 115 bp upstream of the predicted transla- 
tional start site. Reverse transcriptase products were derived from 10 
t~g (frl primer) or 3 I~g (bvg primer) of total RNA from each strain grown 
either in the presence (plus) or absence (minus) of 10 mM nicotinic 
acid. 
by this assay were tested for frl expression. Transcription 
from the frl promoter was detected when BvgAS was inacti- 
vated by the addition of nicotinic acid to the growth medium 
or by deletion ofbvgAS (Figure 2, lanes 6 and 7). Transcrip- 
tion of frl was reduced nearly to background levels in the 
wild-type strain grown under conditions that allow BvgAS 
activity (Figure 2, lane 5). A mutant that is locked in the 
Bvg + growth phase by a constitutive mutation in bvgS 
(bvgS-C3), which renders the system insensitive to modu- 
lation by environmental signals (Miller et al., 1992), failed 
to express frl RNA in the presence of nicotinic acid (Figure 
2, lane 8). These results indicated that BvgAS negatively 
regulates frl expression at the level of transcription. 
The role of frl in flagellar synthesis was investigated by 
constructing a deletion encompassing frlA and frlB (see 
below) in the B. bronchiseptica genome. This mutation 
abrogated motility (data not shown) and the production of 
flagellin (see Figure 3B). Introduction of an episomal copy 
of the frl locus containing the minimal open reading frames 
of frlA and frlB restored motility to the frlAB deletion strain 
(data not shown). Therefore, frlAB is required for motility 
and the production of flagellin in B. bronchiseptica. 
DNA sequence analysis indicated that the frl locus con- 
tains two adjacent open reading frames, frlA and frlB. The 
predicted amino acid sequences of FrlA and FrlB are 
44.6% and 53.7% identical to those of FIhD and FIhC 
(Bartlett et al., 1988), respectively. A plasmid containing 
the minimal frlAB open reading frames complemented E. 
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Figure 3. Reversal of BvgAS-Mediated Control of frl 
(A) The introduction ofthe putative fhaB promoter between the -10 
and -35 region of frl. The fhaB promoter fragment included the site 
required for bvgA-mediated activation, the probable o70 promoter con- 
sensus sequences, and the transcriptional initiation site (see Experi- 
mental Procedures). This construct was exchanged with the native frl 
promoter in B. bronchiseptica toproduce the frl' allele. 
(B) Immunoblot with anti-flagellin monoctonal ntibody, showing flagel- 
lin production in whole-cell ysates of wild type (RB50), frl" (REV1), 
AfrlAB (RBA2), and ,dflaA (RB57) grown with (plus) or without (minus) 
30 mM MgSO,. Lane 7 contains 1 I~g of purified flagellin. Positions of 
molecular mass standard proteins are indicated to the left of lane 1. 
coli flhD and flhC mutations (data not shown), indicating 
that frlAB encodes functional homologs of the flhDC gene 
products. Liu and Matsumara (1994) have provided evi- 
dence that complexes of FIhD and FIhC activate c~ 7°- 
dependent ranscription of flagellar genes by RNA poly- 
merase. Since frlAB can functionally substitute for flhDC, 
it too may encode a transcriptional activator comprised of 
two proteins. The putative promoter region of frl had no 
marked similarities to that of flhDC (data not shown). The 
frl promoter contained a close match to the c~ 7° consensus 
near the transcriptional start site (see legend to Figure 1), 
suggesting that frlA may be transcribed constitutively in 
the absence of BvgAS-mediated repression. 
Reversal of the Transcriptional Control Pattern 
of fr l  Reverses the Expression Pattern 
of the Motility Phenotype 
Characterization of the frl locus and comparisons with the 
E. coli flagellar hierarchy indicated that frl may represent 
a master regulator of motility in B. bronchiseptica. If this 
hypothesis is true, then the observed transcriptional con- 
trol of frl by BvgAS would provide an efficient mechanism 
for regulating the production of the entire motility appara- 
tus. This model predicts that altering the transcription of 
frlwill supplant negative control over flagellar morphogen- 
esis, leading to the production of flagella whenever the frl 
genes are transcribed. To test this hypothesis, we deter- 
mined whether expression of frl from a BvgAS-activated 
promoter would place motility under positive control by 
BvgAS. 
This strategy required an exogenous BvgAS-activated 
promoter that could function as a cassette when removed 
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Figure 4. Electron Micrographs Showing the Production of Flagella in Wild-Type RB50 versus frl r REV1 Strains Grown under Conditions That 
Induce Either the Bvg Phase or the Bvg ÷ Phase 
Bvg- phase, BG plates at 37°C with 30 rnM MgSO4; Bvg ÷ phase, BG plates at 37°C. Scale bar, 0.5 p.M. 
from its native site. Analysis of the fhaB promoter from B. 
pertussis identified cis-acting DNA sequences required for 
BvgAS-mediated activation of fhaB transcription (Roy and 
Falkow, 1991). Speculating that the analogous B. bronchi- 
septica sequences might be sufficient for promoter func- 
tion, we used a 198 bp fragment containing 5' sequences 
of fhaB to drive frl expression (Figure 3A). The frl promoter 
was disrupted by the introduction of the 198 bp fhaB pro- 
moter sequence between the -10 and -35 regions up- 
stream of the transcriptional start site of frl to reduce the 
likelihood of interference by the native promoter. Control 
by BvgAS was examined at the level of motility production, 
flagellar assembly, and flagellin expression in B. bronchi- 
septica containing this frl-reversed mutation (frf). 
Expression of frl from the fhaB promoter in the frl r strain 
REV1 resulted in flagellar morphogenesis in the Bvg + 
growth phase, a phenotypic state in which wild.type organ- 
isms do not express flagella (Figure 4). Inactivation of 
BvgAS prevented the induction of flagellar synthesis in 
REVl. The same regulatory pattern was observed at the 
level of flagellin synthesis (see Figure 3B) and production 
of the motility phenotype (data not shown). These results 
indicate that BvgAS negatively controls motility by inhib- 
iting transcription from the frl promoter. In addition, this 
experiment resulted in the construction of a mutant strain 
in which all vrg loci required for motility are coexpressed 
with the vag loci, reversing the normal pattern of BvgAS- 
mediated control of flagellar synthesis. The interaction be- 
tween this ectopic expression mutant and the host was 
then investigated. 
The Immune Response to Flagellin Provides 
a Reporter for BvgAS-Mediated Phase 
Switching In Vivo 
To examine the role of BvgAS in a biologically relevant 
context, we developed a rat model of infection with B. 
bronchiseptica. I ntranasal inoculation with a very low dose 
of bacteria resulted in colonization (ID~o, <20 CFU [colony- 
forming units]), suggesting that B. bronchiseptica is highly 
adapted to the rat respiratory tract. The kinetics of coloni- 
zation with wild-type B. bronchiseptica re shown in Figure 
6. The infection began in the nasal cavity, consistently 
reached the trachea, and sporadically involved the lungs. 
Sneezing was observed in most infected rats at approxi- 
mately day 5 postinoculation. 
If BvgAS mediates a morphogenic transition in response 
to signals present in the host, then the immune system 
will recognize antigenic proteins specific to both growth 
phases. Such antigenic molecules can serve as indicators 
of bacterial gene expression during colonization. Serum 
from rats infected with wild-type B. bronchiseptica detected 
multiple antigens on immunoblots containing whole-cell 
lysates of Bvg ÷ phase cultures of B. bronchiseptica (Figure 
5A, lanes 5 and 7). The majority of these antigens are 
specific to the Bvg ÷ phase and are not found in Bvg- phase 
cultures (Figure 5A, lanes 6 and 8). In enzyme-linked im- 
munosorbent assays (ELISAs), these sera also reacted 
with purified preparations of filamentous hemagglutinin 
(FHA) protein, a Bvg + phase factor (Figure 5A). These sera 
did not react, however, with Bvg- phase-specific bands 
(Figure 5A, lanes 6 and 8) or with purified flagellin (Figure 
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Figure 5. Serum Antibody Response during 
Infection with Wild-Type and frf Strains 
(A) Western blots were incubated with serum 
obtained from rats 26 days after inoculation 
with wild4ype or frl' strains. A set of rats was 
mock inoculated with PBS as a negative con- 
trol. This panel is representative of additional 
immunoblots conducted with serum from five 
rats in each group. Lanes contain total cell ly- 
sates of the strains indicated above each lane. 
The strains were grown in the presence (plus) 
or absence (minus) of 30 mM MgSO4 as a mod- 
ulator. Purified flagellin (1 ~g) was loaded in 
lanes 12 and 20. Positions of molecular mass 
standard proteins and the band corresponding 
to purified flagellin (arrow) are indicated to the 
right of lane 20. Of the 5 uninfected rats, 2 ex- 
hibited a response to Bordetella ntigens simi- 
lar to the pattern seen in lanes 3 and 4, probably 
representing cross-reactive antibodies gener- 
ated against other flora, since this response 
profile was not seen in Bordetella-infected 
animals. 
(B) Serum was obtained from rats infected with 
the designated strains. Serum antibodies to 
whole cells (left), purified FHA (center), an(; purified fiagellin (right) were detected by ELISA. Serum from one uninfected rat (asterisk) exhibited 
reactivity to B. bronchiseptica in the ELISA, but the same serum used in a Western blot (shown in [A], lanes 3 and 4) exhibited a pattern that 
differs from that of infected rats, probably representing cross-reactive antibodies to other flora. 
5A, lane 12). Similar results were obtained in a rabbit 
model of B. bronchiseptica infection (Cotter and Miller, 
1994). These observations indicate that BvgAS-activated 
genes are expressed during infection, while an immune 
response to Bvg- phase-specif ic proteins is not detected 
by the methods used. 
Failure to detect a serum antibody response to proteins 
specific to the Bvg- phase suggests that genes that are 
negatively controlled by BvgAS are not expressed during 
colonization. Alternatively, the lack of a response to Bvg- 
phase-specif ic factors could result from low immunoge- 
nicity of these proteins. The frl" mutant REV1 was used 
to distinguish between these hypotheses. Flagellar pro- 
duction in REV1 is dependent on the BvgAS-activated 
fhaB promoter, whose expression in vivo has been demon- 
strated by detection of antibodies to FHA during Bordetella 
infections. Therefore, REV1 is predicted to express fla- 
gella during infection. Serum from REVl-infected rats re- 
acted strongly with both flagellin protein on Western blots 
(Figure 5A; compare lanes 12 and 20) and intact flagellar 
organelles in ELISAs (Figure 5B). The immunoblot shown 
in Figure 5A is representative of additional immunoblots 
obtained with serum from five animals in each group. The 
40 kDa antigen corresponding to flagellin was detected 
only with serum from frF-infected rats. Additional Bvg- 
phase-specif ic antigens were not detected. The response 
to 13vgAS-induced antigens was similar in all infected rats. 
Reactivity to a 34 kDa BvgAS-induced band (Figure 5A, 
lanes 5, 7, and 9) was observed in serum from four of the 
rats but did not correlate with the infecting strain, sug- 
gesting some heterogeneity in the response to this antigen 
among individual animals. Antibodies, present only in frlr- 
infected rat serum, uniformly bound to intact flagellar fila- 
ments, as indicated by immunoelectron microscopy (data 
not shown), demonstrating that the response observed in 
ELISAs was not directed to a small proportion of denatured 
epitopes. These results indicate that flagellin is readily 
detected by the rat immune response when it is expressed 
during colonization. The lack of response to flagellin in rats 
infected with wild-type Bordetelia supports the conclusion 
that flagellin is either not expressed during colonization 
or that its expression pattern is limited in duration or mag- 
nitude. 
Ectopic Flagellar Gene Expression Reduces 
Tracheal Colonization by Bordetella 
Lack of detection of vrg expression during infection does 
not preclude the possibility that these genes may play a 
role in pathogenesis. Specific mutations in the regulatory 
pathways controlling vrg loci provide an additional method 
to address this question. A B. bronchiseptica mutant con- 
taining a constitutively active BvgS protein, encoded by 
the bvgS-C3 allele, did not significantly differ from the pa- 
rental strain in its ability to colonize rat tracheas, while 
deletion of bvgS prevented colonization (Figure 6). The 
antibody response, colonization levels, and respiratory 
tract histology in animals infected with the bvgS-C3 strain 
versus the parental strain were also indistinguishable from 
each other in a rabbit model (Cotter and Miller, 1994). 
Since the bvgS-C3 mutant fails to express vrg loci and 
constitutively expresses vag loci under all conditions 
tested, the expression of genes that are repressed by 
BvgAS appears to be inessential for colonization after in- 
tranasal inoculation. The caveat remains, however, that 
conditions unique to growth within a mammalian host may 
modulate the protein product of the bvgS-C3 allele, in 
this case, the in vivo expression pattern of vrg loci in the 
bvgS-C3 strain may resemble that of the wild-type strain 
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Figure 6. Colonization of the Rat Respiratory Tract by Mutants with 
Modified BvgAS Control Pathways 
(Top) The number of CFU recovered in 1 cm of trachea. Rats were 
inoculated with 1 x 104 CFU ofthe strains indicated, with the exception 
of the AbvgAS strain, which was inoculated at 6.5 x 10 s CFU. The 
strains used were as follows: RB50, wt; RB53, bvgS-C3; RBA2, Afrl; 
REV1, frlr; and RB54, AbvgS. The differences between the frl' and 
either the wild-type or the frl deletion strain were statistically significant 
both at day 15 (p < .01 and p < .025, respectively) and at day 26 (p < 
.005 and p < .025, respectively) (two-tailed t test)• The bvgS deletion 
strain (AbvgS) was unable to colonize rats in any anatomical site. 
There were no significant differences in the numbers of CFUs isolated 
from the wild-type strain and either the frl deletion strain or the bvgS-C3 
strain at any time point. At day 15, colonies isolated from two of the 
frlr-infected rats included nonmotile variants. One rat was colonized 
with at least 99% nonmotile variants in the trachea (crossed diamond) 
and 50% nonmotile variants in the nares (asterisk)• This rat was not 
included in the statistical analysis but probably contained fewer than 
102 frl r CFU in the trachea. The second rat was colonized with 3% 
nonmotile variants in the nares, while no B. bronchiseptica were recov- 
ered from its trachea. LLD, lower limit of detection. 
(Bottom) The number of animals in which B. bronchiseptica could be 
detected in the designated anatomical site. 
despite the signal insensitivity conferred by bvgS-C3 in 
vitro. To address directly the quest ion of whether  a 
BvgAS-repressed phenotype is required for colonization, 
we tested mutant RBA2, containing a deletion in f r lAB,  in 
the rat model. No significant difference was detected in 
the number of CFU recovered from the respiratory tracts of 
rats infected with the frl knockout strain versus the number 
from the parental strain, RB50. Productive infection was 
not the result of reversion of the frl mutation, as bacteria 
recovered from RBA2-infected rats remained nonmotile. 
Similar results were obtained with strain RBA6, in which 
a recombinant I~romoter was placed upstream of the f r lAB 
deletion (see below; Figure 7). Together, these data 
strongly support a model in which BvgAS-activated genes 
mediate colonization without an observable requirement 
for BvgAS-repressed genes. 
This model invokes the possibility that the role of nega- 
tive control by BvgAS is to prevent the expression of genes 
that inhibit virulence. To address this question, the frl r mu- 
tant (REV1) was compared with wild-type and Af r lAB  
strains for the ability to colonize rats (Figure 6). All three 
strains colonized the nasal cavities of infected animals at 
day 15 and day 26 postinoculation. Tracheal colonization, 
however, was significantly reduced in the REVl- infected 
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Figure 7. Genetics of the Persistence Defect Conferred by the frl r Mu- 
tation 
(A) Mutations were introduced into the frl' strain to investigate the 
phenotype of defective tracheal colonization. It is possible that the frl' 
phenotype results from expression of potential genes unrelated to 
motility that are cotranscribed with or activated by frl. If the defect 
requires ectopic production of,flagella, however, then deletion of the 
flaA gene is predicted to restore persistence of the frl" strain in the 
trachea. 
(B) Respiratory tract colonization by wild-type (RB50), frl r (REVl), 
frlrAflaA (RBA5), and Afrl' (RBA6). The top shows CFUs isolated from 
1 cm of trachea. Differences between the frl r strain and all other strains 
were statistically significant (p < .005; two-tailed t test). No statistically 
significant differences were detected among the wild-type, frlrAfrl, and 
frlrAflaA strains. The bottom panel indicates the number of rats with 
bacteria at the designated sites in the respiratory tract. In 3 of 5 rats 
infected with the frl' strain, nonmotile variants were detected in the 
nares at frequencies of approximately 18o/0, 210/0, and 50/0 (asterisk) 
(n = 100 colonies tested per rat). LLD, lower limit of detection. 
rats as compared with the controls at both timepoints. No 
CFU were detected in the tracheas of REVl- infected rats 
at day 26, while the wild-type strain persisted in the trachea 
to at least day 50. When B. bronchiseptica colonies iso- 
lated from REVl- infected rats were screened for motility, 
nonmoti le mutants were detected in populations isolated 
from 2 of the 5 rats sacrificed at day 15 in one experiment 
(Figure 6) and 3 of the 5 rats sacrificed at day 26 in a second 
experiment (Figure 7B). These variants were nonmoti le 
under Bvg ÷ and Bvg- conditions, indicating that they did 
not represent revertants of REVl  to wild-type. Experi- 
ments with REVl- infected rabbits (data not shown) also 
yielded nonmoti le variants in 2 of 4 infected animals. Both 
REVl  grown in vitro and RB50 grown in animals or on 
plates failed to give rise to nonmoti le mutants in a sample 
of 1000 colonies tested per strain. The in vivo selection 
of nonmoti le mutants in the frF background and reduced 
colonization by REV1 indicate a requirement for negative 
control of frl by BvgAS during respiratory tract infection 
by B. bronchiseptica. 
Several mechanisms could lead to the observed survival 
defect of REVl  (Figure 7A). It is possible that the f r loperon  
contains loci downstream of f r lAB that are cotranscribed 
with these genes and could potential ly cause the Frl r phe- 
notype during infection. Alternatively, the in vivo defect of 
the frl' mutant may result from expression of f r lAB- regu-  
~ated loci that include motil ity genes and, potentially, 
genes that are not involved in motility. If the defective colo- 
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nization pattern specifically requires ectopic flagellar mor- 
phogenesis, then disruption of a late gene in the flagellar 
control pathway should restore wild-type colonization lev- 
els to the frl ~ strain. An in-frame deletion was therefore 
introduced into the flaA gene of the frf mutant. This 
frl~AflaA strain was tested in the r~t model to assess the 
basis of the persistence defect. The frlr/lflaA mutant exhib- 
ited wild-type colonization levels, indicating that ,JflaA is 
epistatic to frl' (Figure 7B). As predicted, disruption of frlAB 
also abrogated the in vivo defect conferred by the frl r muta- 
tion. These results indicate that potential frl-regulated or 
cotranscribed genes that are independent of the motility 
phenotype are not responsible for the defect induced by 
ectopic frl expression. Furthermore, the evidence strongly 
supports the hypothesis that inappropriate xpression of 
the flagellar regulon itself disrupts development of the in- 
fection. 
Discussion 
The diverse environments inhabited by bacteria provide 
a wide range of settings in which a signal transduction 
event may be biologically relevant. To maximize the oppor- 
tunity to detect significant aspects of BvgAS-mediated sig- 
nal transduction, we chose a model that is expected to 
duplicate closely the natural events in the life cycle of a 
respiratory pathogen. Intranasal inoculation of rats with 
B. bronchiseptica t doses lower than 20 CFU results in 
infection. This infection persists for at least 50 days, pro- 
ducing mild signs of respiratory disease in the form of 
sneezing early in the infection. It seems likely that many 
events that occur during the B. bronchiseptica life cycle 
can be observed in this animal model. We investigated 
the requirement for BvgAS-mediated signal transduction 
during the development of infection by using B. bronchi- 
septica mutants that lack specific regulatory pathways 
within the BvgAS regulon. Our results indicate that the 
full colonization potential of B. bronchiseptica can only 
be attained when, in addition to producing factors that 
mediate host-microbe interactions, the bacterium is also 
capable of negatively regulating factors that inhibit devel- 
opment of the infection. 
Identification of the Control Point at Which 
BvgAS Represses Motility 
Analysis of BvgAS-regulated genes identified a control 
mechanism for the phenotype of motility in B. bronchisep- 
tica. These studies revealed a transcriptional cascade 
whose organization, component genes, and flagellar phe- 
notype exhibited similarity to that of E. coil (Figure 1). The 
gene encoding the major structural component of the fla- 
gellar filament in B. bronchiseptica, flaA, complements 
mutations in the E. coli flagellin gene, fliC. DNA sequence 
analysis and functional complementation of E. coli flhDC 
mutants identified the frlAB operon as a potential analog 
of flhDC, which encodes an activator of flagellar gene ex- 
pression (Liu and Matsumura, 1994; Komeda, 1982). The 
systems differ, however, in at least one major aspect. 
While E. coli motility is positively controlled by a nutrient 
deprivation signal, B. bronchiseptica motility is repressed 
by the virulence control system. 
The differences in regulation of motility can be attributed 
to differences in the promoters of master control loci in 
the two species. DNA sequence comparisons, mRNA 
analysis, and genetic data support this conclusion. Al- 
though we cannot rule out the possible existence of a 
BvgAS-repressed activator of frl, the frl promoter contains 
a strong (~70 consensus sequence near the transcriptional 
start site, suggesting that it should function constitutively 
in the absence of repression by BvgAS. Consistent with 
this hypothesis, ablation of the BvgAS system confers the 
production of motility and flagella under all conditions 
tested. The E. coil flhDC promoter region contains a site 
similar to sequences known to recruit the product of the 
crp gene when it is activated by the presence of cAMP, 
leading to transcriptional activation (Bartlett et al., 1988). 
Motility and transcription of flagellar genes in E. coil re- 
quire the crp locus, and mutations located in the putative 
promoter of the flhDC operon render E. coil motility inde- 
pendent of crp (Silverman and Simon, 1977), suggesting 
that cAMP-CRP activates transcription from the flhDC pro- 
moter, leading to expression of the flagellar hierarchy. It 
is evident that frlAB fulfills a role similar to that of flhDC, 
since replacement of the native frl promoter with the 
BvgAS-activated fhaB promoter renders motility depen- 
dent on BvgAS. Therefore, BvgAS regulates the produc- 
tion of flagella and motility primarily at the level of frl tran- 
scription. 
Colonization by B. bronchiseptica Does Not 
Require vrg Loci 
The role of motility has been examined in a number of 
host-parasite interactions. In Salmonella typhimurium, 
the role of motility in virulence appears to be subtle (Jones 
et al., 1992; Schmitt et al., 1994). However, in studies 
of Vibrio fischeri, Graf et al. (1994) have demonstrated a 
requirement for motility in colonization of host light organs. 
In S. typhimurium, motility is estimated to require at least 
50 genes found in 13 separate operons (Macnab, 1992) 
and requires a significant proportion of the energy of the 
cell. Since this complex phenotype is conserved among 
B. bronchiseptica strains (Akerley et al., 1992), it seems 
likely that it is required for survival of the bacterium. The 
role of motility in the interaction of B. bronchiseptica with 
the host was directly tested with mutants (RBA2 and 
RBA6) in which the frlAB locus was deleted. These mu- 
tants were completely defective in the production of fla- 
gella and motility. They showed no defect, however, in 
colonization or persistence in the rat model. These results 
are consistent with the observation that the bvgS-C3 mu- 
tant, in which the expression of vrg loci cannot be detected, 
also shows no defect in the rat model (Figure 6). Therefore, 
we have conclusively demonstrated that genes subject to 
negative control by BvgAS are not required for coloniza- 
tion of the rat respiratory tract by B. bronchiseptica. 
This outcome was unexpected, as a vrg mutant (vrg-6) 
obtained by transposon mutagenesis of B. pertussis con- 
fers reduced bacterial persistence in a mouse model 
(Beattie et al., 1992). Two possibilities could account for 
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this difference. One possibility is that the BvgAS systems 
of the two species may respond to environments that se- 
lect for different raits in the Bvg- phase. Some support 
for this hypothesis can be drawn from the observation that 
B. bronchiseptica does not express vrg-6 and B. pertussis 
is nonmotile, indicating that the Bvg- phases of the two 
organisms are quite different, in contrast with the exten- 
sive similarities between their BvgAS-activated genes. Al- 
ternatively, the mouse model may exert artificial selection 
for certain phenotypes, since the mouse is not a natural 
host of B. pertussis. 
It is possible that some defects in the long-term survival 
strategy of a bacterium could produce only subtle changes 
in either colonization profiles or bacterial ocalization. The 
expression of vrg loci may still occur during infection de- 
spite the lack of a detectable colonization defect. To inves- 
tigate this possibility, the host antibody response was used 
to detect in vivo expression of flagellin. If the BvgAS- 
mediated phase transition occurs during growth within a 
host, then the immune system of the host should detect 
antigens specific to both phases. No antibodies to flagella 
were detected during infection with wild-type B. bronchi- 
septica. 
It has been proposed that the Bvg- phase is relatively 
nonimmunogenic and that down-regulation of BvgAS- 
activated genes represents a means by which Bordetella 
may avoid destruction by the immune response (Lacey, 
1960). Lack of an antibody response to Bvg- phase-spe- 
cific factors may result from either a lack of expression 
of vrg loci or the lack of immunogenicity of vrg-encoded 
proteins. We addressed this question in B. bronchiseptica 
by using the frl' mutant, infection by the frl ~ mutant, which 
expresses flagella ectopically during the Bvg + phase, re- 
sulted in a strong antibody response to flagella. This result 
indicates that flagella are immunogenic when expressed 
during colonization. Although it remains possible that ex- 
pression of flagella in the wild-type strain may occur in an 
immunologically sequestered niche or stage of infection, 
the absence of a response to flagella during wild-type in- 
fections suggests that motility is not normally induced 
within the host. 
The precise role of vrg loci during a natural infection 
has yet to be demonstrated. One possibility is that the 
Bvg- phase occurs during transmission between hosts, 
followed by a rapid transition to the Bvg ÷ phase upon en- 
countering a new host. Consistent with this hypothesis, 
recent data indicates that Bvg- phase B. bronchiseptica 
have a survival advantage under nutrient-limiting condi- 
tions as compared with Bvg ÷ phase cultures (Cotter and 
Miller, 1994). Such conditions may exist in the environ- 
ment encountered by bacteria in transit between mamma- 
lian hosts. To test this hypothesis, our current experiments 
focus on the development of a model to observe transmis- 
sion of B. bronchiseptica between animals. 
Negative Regulation by BvgAS Is Required 
during Colonization 
The observation that virulence control loci mediate pleio- 
tropic gene activation and repression suggests that these 
systems respond to signals within the host. Notably, the 
phoP/phoQ system in S. typhimurium both activates and 
represses genes implicated in pathogenesis (Behlau and 
Miller, 1993). Our data suggest that a BvgAS-mediated 
biphasic switch in gene expression patterns is not required 
during colonization. If this conclusion is true, then what 
is the importance of BvgAS-mediated regulation? This 
question was addressed by reversing the control of motility 
by BvgAS. The frl' mutant (REVl) produces flagella under 
conditions that activate BvgAS, leading to negative control 
of motility in the wild-type strain. This mutation resulted 
in reduced persistence in the tracheas of infected rats. 
Nonmotile derivatives of REVl arose during infection but 
were not detected in vitro. Since no defect was observed 
in the AfrlAB strain or in the Afrl r strain, reduced persis- 
tence of the frl r strain can be attributed to expression of 
frl in the Bvg ÷ phase. Restoration of persistence in the 
frl~AflaA strain implicates ectopic flagellar synthesis in the 
attenuation of virulence in the frl" mutant. This result pre- 
cludes the possibility that a frl-dependent locus distinct 
from those involved in motility is required for the defect. 
Immunoblots indicate that the frr mutation does not alter 
the overall expression pattern or antibody response to the 
Bvg ÷ phase-specific antigens (Figure 5). The defect in 
persistence may result from the introduction of a novel 
immunogenic target, such as the flagellum, on the cell 
surface. Alternatively, motility may disrupt the ability of 
toxins and adhesins to function at their relevant sites of 
action. While the precise mechanism of attenuation is cur- 
rently unknown, the defective interaction of the frl ~ mutant 
with the host demonstrates the essential nature of nega- 
tive control by BvgAS during pathogenesis. The impor- 
tance of repressing factors that inhibit virulence seems to 
rival that of activating factors that are required for viru- 
lence. 
Experimental Procedures 
B. bronchiseptica Strains 
Wild-type B. bronchiseptica strain RB50 was isolated in our laboratory 
from a naturally infected rabbit (Cotter and Miller, 1994). Wild-type B. 
bronchiseptica strain GP1SN was isolated from an infected guinea 
pig (Akerley et al., 1992). DM106 and RB53 contain mutations of 1 
bp in bvgS corresponding tothe B. pertussis bvg-C3 allele conferring 
the BvgAS-constitutive phenotype in both bacterial species. DM107 
contains a deletion of the entire bvgAS locus. RB54 contains an in- 
frame deletion i  bvgS. The mutations inthe bvgAS loci of these strains 
were constructed by allelic exchange, as has been described (Akerley 
et al., 1992; Cotter and Miller, 1994). Mutations in flagellar genes were 
constructed by using an allelic exchange system that allows election 
for the introduction funmarked mutations by the resolution of chromo- 
somal cointegrates. Mutational junctions within genes were confirmed 
by DNA sequencing. Inserts containing deletions in frlAB or flaA 
flanked by sequence homologous to the wild-type allele were cloned 
into pEGBR for the construction ofB. bronchiseptica strains RBA2 and 
RB57, respectively, pEGBR is a Pstl deletion derivative of pSSl129 
(Stibitz and Yang, 1991) containing the sacBR gene cartridge from 
pUM24 (Reid and Collmer, 1987) and the RP4 origin of transfer, which 
can be mobilized from E. coli SM10 to confer ampicillin resistance, 
kanamycin resistance, and sucrose sensitivity. Transconjugants were 
grown on media containing streptomycin (40 i~g/ml) to select against 
E. coil donors and kanamycin (40 pg/ml) to select for B. bronchiseptica 
recipients, This treatment selected for integration ofthe plasmid, since 
pEGBR does not replicate autonomously in Bordetella. Excision of the 
integrated plasmids occurred uring growth on nonselective media. 
Subsequent growth on Luria broth (LB)-sucrose selected for cells that 
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had undergone the second homologous recombination event as deter- 
mined by the loss of kanamycin resistance. Approximately 50% of 
the resulting clones exhibited loss of motility as predicted, since the 
exchange vector carried equal lengths of homologous sequences 
flanking each mutation. The genotypes of strains expressing mutant 
phenotypes were confirmed by Southern blot analysis of genomic DNA 
(data not shown). Complamentation of specific deletion mutations by 
the minimal open reading frames of the wild-type alleles carried on 
mobilizable plasmid pRK290 (tetracycline-resistant) confirmed that the 
genomic mutations conferred the observed motility defects. 
To create the frf strain, REVl, fhaB promoter sequences were ampli- 
fied by polymerase chain reaction (PCR) from pDM31 containing the 
B. bronchieeptica fhaB promoter. This fragment contained a potential 
BvgA-binding site (5'-AGGAAATTTCCTA) at the same position as the 
site found in the B. pertussis promoter. The primers used (5'-GCGAC- 
ATGTCGGCGCACGCCTATACG and 5'-CAGACATGTGAAGTAATC- 
GGCAGAATC) contain Aflll sites that were used to introduce the fhaB 
promoter (from position -16 to position -209 relative to the predicted 
translational start site) into the Ncol site upstream of the frlA gene. A 
DNA fragment containing the altered frl promoter was then cloned into 
pEGBR for allelic exchange (as described above) in RB50 and RB54. 
The position of the fhaB promoter was confirmed by sequence analy- 
sis. The genomic mutations were confirmed by Southern blot analysis 
(data not shown). RB54 frl' was nonmotile, while RB50 frl' was motile 
only under Bvg ÷ conditions. All B. bronchiseptica strains were main- 
tained as frozen stocks at -70°C or grown on Bordet-Gengou (BG) 
agar containing 7.5% defibrinated sheep blood at 37°C, which permits 
the observation of hemolysis. 
Experimental Animals 
Wistar rats were obtained at 3-4 weeks of age from Charles River 
Laboratories (Wilmington, MA). Several animals from each lot were 
euthanized by halothane inhalation upon arrival and determined to be 
free of B. bronchiseptica infection upon necropsy (see below). Rats 
were briefly anesthetized with aeroeolized halothane and inoculated 
intranasally with 10 p.I of B. bronchiseptica in sterile PBS (phosphate- 
buffered saline). Inocula were grown at 37°C in Stainer-Scholte media 
and normalized by optical density at 600 nm. The number of CFU 
delivered was determined by plating dilutions on BG plates. Rats were 
monitored daily for signs of respiratory distress. Sneezing was ob- 
served at approximately day 3 through day 7 postinoculation in infected 
rats but not in uninfected rats, At the designated timepoints, postinocu- 
lation rats were euthanized by halothane inhalation, and serum sam- 
ples were obtained by cardiac puncture. Lungs were added to 3 ml of 
PBS in a sterile plastic bag (Tekmar, Cincinnati, OH) and homogenized 
manually by rolling a cylinder across the bag, extruding the tissue in 
a fine suspension. Tracheas were ground with a Teflon homogenizer 
in microfuge tubes containing 200 p.I of ice-cold PBS. Dilutions of 
homogenized tissues were plated on BG agar and cultured at 37°C 
for 2 days for determination of CFU. Deep nasal swabs were obtained 
by first removing the distal naris and then swabbing the nasal turbi- 
nates with a calcium alginate swab. Nasal swabs were plated on BG 
agar with or without cephalothin, which prevents growth of the normal 
flora but does not affect B. bronchieeptica. B. bronchiseptica was the 
predominant isolate from rats infected with this bacterium, while rats 
free of B. bronchieeptica were colonized with a diverse array of normal 
flora. Mock-infected rats housed in cages adjacent to rats inoculated 
with B. bronohiseptica did not become infected with B. bronchiseptioa. 
Experiments with rabbits were performed as described previously (Cot- 
ter and Miller, 1994). 
Molecular Biology 
Manipulations of nucleic acids were performed according to standard 
protocols (Sambrook et al., 1989). DNA sequence analysis was con- 
ducted using Sequenase version 2.0 (US Biochemical Corporation, 
Cleveland, OH) essentially by the method of Sanger et al. (1977). 
Sequences were analyzed with the University of Wisconsin sequence 
analysis software (Devereux et al., 1984). Bacterial RNA was isolated 
from cultures growing exponentially in Stainer-Scholte media (Stainer 
and Scholte, 1971) and subjected to primer extension analysis as pre- 
viously described (Akerley and Miller, 1993). 
Electron Microscopy 
Bordetella cells grown on BG agar with or without modulators that 
inhibit BvgAS activity were resuspended in PBS and transferred to 
Formvar-coated nickel grids. Immunoelectron microscopy was per- 
formed as described previously (Harlow and Lane, 1988), with rat sera 
diluted 1:20 as the primary antibody and colloidal gold-labeled goat 
anti-rat IgG diluted 1:20 as the secondary antibody. Grids were exam- 
ined in an electron microscope (JEOL 100CX) at 80 kV of accelerating 
voltage. 
Western Immunoblotting 
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS- 
PAGE) was performed by the method of Laemmli (1970), using de- 
naturing 4%-12% linear gradient gels. Proteins were transferred to 
Immobilon P membranes (Millipore) and reacted with rat serum at 
dilutions of 1:2000. Rat antibody was detected with a goat anti-rat 
antibody conjugated to horseradish peroxidaee at a dilution of 1:3000 
by use of an enhanced chemiluminescence technique (Amersham). 
Flagellin was detected on immunoblots by a mouse monoclonal anti- 
body described by Feng et al. (1990) used at a dilution of 1:2000. 
Antigen-antibody complexes were then detected with a goat anti- 
mouse horseradish peroxidase-conjugated antibody (at 1:2000) as 
described above. 
ELISA 
Antibody titers were quantitated by ELISA as previously described 
(Cotter and Miller, 1994; Hudson and Hay, 1989). FHA purified from 
B. pertussis was obtained from Lederle-Praxis Biologicals (West Hen- 
rietta, NY). Flagellar filaments were purified from RB50 by CsCI equilib- 
rium density gradient centrifugation as previously described (Akerley 
et al., 1992). 
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